Maurizio Bruschi Selected Research

Medullary Sponge Kidney

6/2022	A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease.
1/2021	Sphingomyelin and Medullary Sponge Kidney Disease: A Biological Link Identified by Omics Approach.
11/2019	Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease.
1/2019	Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease.
1/2017	Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Bruschi Research Topics

Disease

17	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2021 - 07/2002
15	Proteinuria 01/2021 - 02/2002
13	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2020 - 12/2002
12	Lupus Nephritis 12/2021 - 03/2010
12	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 02/2003
7	Neoplasms (Cancer) 12/2021 - 12/2009
7	Glomerulonephritis 12/2021 - 05/2006
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2021 - 01/2017
6	Infections 05/2022 - 01/2018
5	Medullary Sponge Kidney 06/2022 - 01/2017
5	Rheumatoid Arthritis 12/2021 - 08/2015
5	Fibrosis (Cirrhosis) 01/2017 - 08/2004
4	Inflammation (Inflammations) 11/2021 - 11/2005
4	Nephrolithiasis 01/2021 - 01/2017
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2022 - 03/2007
3	Vasculitis (Vasculitides) 01/2020 - 01/2017
2	Sclerosis 10/2021 - 12/2002
2	Kidney Diseases (Kidney Disease) 10/2020 - 01/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2015
2	Asthma (Bronchial Asthma) 01/2015 - 11/2005
2	IGA Glomerulonephritis (IGA Nephropathy) 07/2013 - 09/2012
2	Hypercholesterolemia 02/2003 - 12/2002
1	Preterm Premature Rupture of the Membranes 11/2021
1	Premature Birth (Birth, Premature) 11/2021
1	Rupture 11/2021
1	Peritoneal Fibrosis 10/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Medulloblastoma 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 01/2021
1	Glioma (Gliomas) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Premature Obstetric Labor (Premature Labor) 01/2020
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2019
1	Exanthema (Rash) 01/2018
1	Atrial Fibrillation 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Fever (Fevers) 01/2018
1	Cough 01/2018
1	Myocardial Infarction 01/2018
1	Lung Injury 01/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2017

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2002
18	AntibodiesIBA 10/2021 - 11/2007
9	AutoantibodiesIBA 12/2021 - 09/2012
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2008
8	AlbuminsIBA 12/2013 - 04/2003
7	Immunoglobulin G (IgG)IBA 12/2021 - 03/2010
7	SteroidsIBA 10/2021 - 12/2002
7	AntigensIBA 12/2020 - 02/2011
6	ProteomeIBA 01/2021 - 07/2013
5	Phosphopyruvate Hydratase (Enolase)IBA 12/2020 - 09/2011
4	CalciumIBA 01/2021 - 01/2017
4	Blood Proteins (Serum Proteins)IBA 01/2009 - 02/2002
3	Biological ProductsIBA 11/2021 - 07/2017
3	Deoxyribonucleases (DNase)FDA Link 10/2021 - 01/2020
3	Aldehyde Reductase (Aldose Reductase)IBA 12/2020 - 03/2010
3	Complement System Proteins (Complement)IBA 11/2019 - 12/2002
3	Immunoglobulin M (IgM)IBA 10/2019 - 04/2003
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 08/2015
2	Rituximab (Mabthera)FDA Link 10/2021 - 01/2018
2	ofatumumab FDA Link 10/2021 - 01/2018
2	AutoantigensIBA 12/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2017 - 12/2011
2	CytokinesIBA 10/2013 - 11/2005
2	Low Density Lipoprotein Receptor-Related Protein-2IBA 04/2012 - 02/2011
2	AntioxidantsIBA 01/2008 - 10/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2007 - 07/2002
2	Serum AlbuminIBA 03/2007 - 10/2006
1	Protein Kinases (Protein Kinase)IBA 06/2022
1	Prednisone (Sone)FDA LinkGeneric 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Calcineurin InhibitorsIBA 10/2021
1	thymosin beta(4)IBA 01/2021
1	SphingomyelinsIBA 01/2021
1	MetalsIBA 01/2021
1	VaccinesIBA 01/2021
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2021
1	ThrombospondinsIBA 12/2020
1	Phospholipase A2 ReceptorsIBA 12/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	methionine sulfoxideIBA 01/2019
1	Tetradecanoylphorbol AcetateIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Peptides (Polypeptides)IBA 05/2018
1	Annexin A1IBA 05/2018
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2018
1	Fluconazole (Zonal)FDA LinkGeneric 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 12/2017
1	Laminin (Merosin)IBA 01/2017

Therapy/Procedure

4	Therapeutics 10/2019 - 11/2007
3	Peritoneal Dialysis 05/2022 - 02/2015
2	Plasmapheresis 11/2007 - 07/2002
1	Renal Dialysis (Hemodialysis) 05/2022
1	Premedication 01/2018
1	Length of Stay 01/2018